Cargando…
mTOR inhibitors induce apoptosis in colon cancer cells via CHOP-dependent DR5 induction upon 4E-BP1 dephosphorylation
The mammalian target of rapamycin (mTOR) is commonly activated in colon cancer. mTOR complex 1 (mTORC1) is a major downstream target of the PI3K/ATK pathway and activates protein synthesis by phosphorylating key regulators of mRNA translation and ribosome synthesis. Rapamycin analogs Everolimus and...
Autores principales: | He, Kan, Zheng, Xingnan, Li, Mei, Zhang, Lin, Yu, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603992/ https://www.ncbi.nlm.nih.gov/pubmed/25867072 http://dx.doi.org/10.1038/onc.2015.79 |
Ejemplares similares
-
4EGI-1 induces apoptosis and enhances radiotherapy sensitivity in nasopharyngeal carcinoma cells via DR5 induction on 4E-BP1 dephosphorylation
por: Wang, Weiyuan, et al.
Publicado: (2016) -
Lestaurtinib potentiates TRAIL‐induced apoptosis in glioma via CHOP‐dependent DR5 induction
por: Cao, Yingxiao, et al.
Publicado: (2020) -
Induction of DR5-Dependent Apoptosis by PGA(2) through ATF4-CHOP Pathway
por: Park, Kyeong-Min, et al.
Publicado: (2022) -
mTOR inhibitor efficacy is determined by the eIF4E/4E-BP ratio
por: Alain, Tommy, et al.
Publicado: (2012) -
mTOR inhibitor Everolimus-induced apoptosis in melanoma cells
por: Ciołczyk-Wierzbicka, Dorota, et al.
Publicado: (2019)